Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Rosellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F., A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience, «ESMO OPEN», 2024, 9, Article number: 103448, pp. 1 - 8 [articolo]Open Access
Oprea-Lager DE, MacLennan S, Bjartell A, Briganti A, Burger IA, de Jong I, De Santis M, Eberlein U, Emmett L, Fizazi K, Gillessen S, Herrmann K, Heskamp S, Iagaru A, Jereczek-Fossa BA, Kunikowska J, Lam M, Nanni C, O'Sullivan JM, Panebianco V, Sala E, Sathekge M, Sosnowski R, Tilki D, Tombal B, Treglia G, Tunariu N, Walz J, Yakar D, Dierckx R, Sartor O, Fanti S., European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer., «EUROPEAN UROLOGY», 2024, 85, pp. 49 - 60 [articolo]Open Access
Vetrone L, Fortunati E, Castellucci P, Fanti S., Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?, «SEMINARS IN NUCLEAR MEDICINE», 2024, 54, pp. 150 - 162 [articolo]
Droghetti M.; Bianchi L.; Presutti M.; Vetrone L.; Farolfi A.; Mei R.; Giunchi F.; Degiovanni A.; Mottaran A.; Piazza P.; Cangemi D.; Castellucci P.; D'Errico A.; Schiavina R.; Brunocilla E.; Fanti S., Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection, «FRONTIERS IN ONCOLOGY», 2024, 14, Article number: 1324631, pp. 1 - 12 [articolo]
Voltin C.-A.; Paccagnella A.; Winkelmann M.; Heger J.-M.; Casadei B.; Beckmann L.; Herrmann K.; Dekorsy F.J.; Kutsch N.; Borchmann P.; Fanti S.; Kunz W.G.; Subklewe M.; Kobe C.; Zinzani P.L.; Stelljes M.; Roth K.S.; Drzezga A.; Noppeney R.; Rahbar K.; Reinhardt H.C.; von Tresckow B.; Seifert R.; Albring J.C.; Blumenberg V.; Farolfi A.; Flossdorf S.; Godel P.; Hanoun C., Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2024, 51, pp. 1361 - 1370 [articolo]Open Access
Adebahr S, Althaus A, Scharl S, Strouthos I, Farolfi A, Serani F, Lanzafame H, Trapp C, Koerber SA, Peeken JC, Vogel MME, Vrachimis A, Spohn SKB, Grosu AL, Kroeze SGC, Guckenberger M, Fanti S, Hruby G, Emmett L, Belka C, Schmidt-Hegemann NS, Henkenberens C, Aebersold DM, Wiegel T, Afshar-Oromieh A, Zamboglou C, Shelan M., The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2024, 51, pp. 558 - 567 [articolo]Open Access
Zagni F.; Vichi S.; Paolani G.; Santoro M.; Della Gala G.; Strolin S.; Castellucci P.; Vetrone L.; Fanti S.; Morganti A.G.; Strigari L., A novel tool for predicting the dose distribution of non-sealed 188Re (Rhenium) resin in non-melanoma skin cancers (NMSC) patients, «MEDICAL PHYSICS», 2023, 50, pp. 4600 - 4612 [articolo]Open Access
Serani F.; Fendler W.P.; Castellucci P.; Berliner C.; Barbato F.; Herrmann K.; Farolfi A.; Fanti S., A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients, «CANCERS», 2023, 15, Article number: 2208, pp. 1 - 9 [articolo]Open Access
Mattana F.; Zanoni L.; Nanni C.; Mosconi C.; Brocchi S.; Golfieri R.; Fanti S., Actionable imaging findings in the daily PET/CT scenario, «CLINICAL AND TRANSLATIONAL IMAGING», 2023, 11, pp. 127 - 139 [articolo]
Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G, Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2023, 50, pp. 572 - 580 [articolo]Open Access
Caterina Gaudiano, Margherita Mottola, Lorenzo Bianchi, Beniamino Corcioni, Lorenzo Braccischi, Makoto Taninokuchi Tomassoni, Arrigo Cattabriga, Maria Adriana Cocozza, Francesca Giunchi, Riccardo Schiavina, Stefano Fanti, Michelangelo Fiorentino, Eugenio Brunocilla, Cristina Mosconi, Alessandro Bevilacqua, An Apparent Diffusion Coefficient-based machine learning model can improve Prostate Cancer detection in the grey area of the PI-RADS 3 category: a single-centre experience, «CANCERS», 2023, 15, Article number: 3438, pp. 1 - 12 [articolo]Open Access
Ferrandez M.C.; Golla S.S.V.; Eertink J.J.; de Vries B.M.; Lugtenburg P.J.; Wiegers S.E.; Zwezerijnen G.J.C.; Pieplenbosch S.; Kurch L.; Huttmann A.; Hanoun C.; Duhrsen U.; de Vet H.C.W.; Hoekstra O.S.; Burggraaff C.N.; Bes A.; Heymans M.W.; Jauw Y.W.S.; Chamuleau M.E.D.; Barrington S.F.; Mikhaeel G.; Zucca E.; Ceriani L.; Carr R.; Gyorke T.; Czibor S.; Fanti S.; Kostakoglu L.; Loft A.; Hutchings M.; Lee S.T.; Zijlstra J.M.; Boellaard R., An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients, «SCIENTIFIC REPORTS», 2023, 13, Article number: 13111, pp. 1 - 11 [articolo]Open Access
Bolton R.C.D.; Calapaqui Teran A.K.; Herrmann K.; Fanti S.; Giammarile F., Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors with the Clinical Application of FAPI Imaging?, «CLINICAL NUCLEAR MEDICINE», 2023, 48, pp. 318 - 319 [articolo]
Pensato U.; Amore G.; Muccioli L.; Sammali S.; Rondelli F.; Rinaldi R.; D'Angelo R.; Nicodemo M.; Mondini S.; Sambati L.; Asioli G.M.; Rossi S.; Santoro R.; Cretella L.; Ferrari S.; Spinardi L.; Faccioli L.; Fanti S.; Paccagnella A.; Pierucci E.; Casadei B.; Pellegrini C.; Zinzani P.L.; Bonafe M.; Cortelli P.; Bonifazi F.; Guarino M., CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study, «JOURNAL OF NEUROLOGY», 2023, 270, pp. 2659 - 2673 [articolo]
Vetrone L.; Cuzzani G.; Mei R.; Zanoni L.; Bertaccini A.; Bianchi L.; Castellucci P.; Gaudiano C.; Cappelli A.; Giunchi F.; Fanti S., Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge, «FRONTIERS IN ONCOLOGY», 2023, 13, Article number: 1101221, pp. 1 - 5 [articolo]Open Access
Vetrone, Luigia; Cuzzani, Giulia; Mei, Riccardo; Zanoni, Lucia; Bertaccini, Alessandro; Bianchi, Lorenzo; Castellucci, Paolo; Gaudiano, Caterina; Cappelli, Alberta; Giunchi, Francesca; Fanti, Stefano, Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge, «FRONTIERS IN ONCOLOGY», 2023, 13, Article number: 1101221, pp. 1 - 5 [articolo]Open Access
